Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis

Abstract

Novel mitochondria-targeted antioxidants could be promising components of combined programs for MS therapy considering that they can be applied at extremely low doses and concurrently demonstrate anti-inflammatory and neuroprotective activities.